The global respiratory filters market size is expected to reach USD 802.4 million by 2030, registering a CAGR of 5.5% from 2023 to 2030, according to a new study by Grand View Research, Inc. Growth in the market is driven by the increasing prevalence of chronic respiratory diseases, strategic initiatives by organizations, technological advancements, and the cost-effectiveness of the devices. Moreover, the increased awareness about respiratory health and the importance of preparedness for future respiratory emergencies have highlighted the need for improved respiratory support infrastructure. As a result, governments and healthcare institutions may invest in upgrading and expanding their respiratory device capabilities, thus holding potential growth for the market.
According to the CDC, the incidence of Tuberculosis (TB) (cases per 100,000 population) among Americans increased from 0.71 in 2020 to 0.79 in 2021, while it grew from 11.71 in 2020 to 12.16 in 2021 among non-Americans. Growing number of patients with TB further increases the demand for respiratory care devices used in TB therapy. For instance, during and after TB treatment, respirators, nebulizers, polysomnography devices, BiPAP devices, etc., are frequently utilized, which, in turn, is boosting the demand for respiratory care devices, including respiratory filters. The COVID-19 pandemic has been advantageous for the overall market, and it has had a positive impact on its growth. The demand for some key products, such as ventilators, Continuous Positive Airway Pressure (CPAP) machines, and oxygen concentrators increased by 4-5 times, thereby driving market growth. While the pandemic drove the initial surge in demand, the long-term market outlook for respiratory filters remains positive.
Request a free sample copy or view report summary: Respiratory Filters Market Report
The overall market growth is attributed to the increasing prevalence of respiratory diseases, such as asthma and COPD, and the rising global geriatric population
The positive airway pressure device filters segment accounted for the largest revenue share of 23.9% in 2022. The growing patient pool suffering from obstructive sleep apnea is expected to drive the demand for PAP devices
The hospitals end-use segment dominated the market with a revenue share of 33.93% in 2022 and is expected to continue its dominance with the fastest CAGR of 5.9% over the forecast period
North America dominated the market and accounted for the largest share of 37.2% in 2022 due to the continuous product launches and availability of the latest technologies
Grand View Research has segmented the global respiratory filters market on the basis of product, end-use, and region:
Respiratory Filters Product Outlook (Revenue, USD Million, 2018 - 2030)
Nebulizer Filters
Inlet Filter
Replacement Filter
Cabinet Filter
Humidifier Filters
Wick Filter
Permanent Cleanable Filter
Mineral Absorption Pads
Demineralization Cartridges
Positive Airway Pressure Device Filters
Ultra-fine Foam Inlet Filter
Polyester Non-woven Fiber Filter
Acrylic & Polypropylene Fiber Filter
Oxygen Concentrators Filters
HEPA Filter
Cabinet Filter
Pre-Inlet Filter
Inlet Filter
Micro Disk Filter
Felt Intake Filter
Bacterial Filter
Hollow-membrane Filter
Ventilator Filters
Mechanical Filters
Electrostatic Filters
Respiratory Filters End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Home Care
Respiratory Filters Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
Lits of Key Players in the Respiratory Filters Market
GE Healthcare
Koninklijke Philips N.V.
ICU Medical (Smiths Medical)
Invacare Corporation
Medtronic
Fisher & Paykel Healthcare
ResMed
Linde
Mindray
Chart Industries
Drägerwerk AG & Co. KGaA
DeVilbiss Healthcare
"The quality of research they have done for us has been excellent..."